The need for biopharma executives to combine a "culture of quality" with value-added processes and improvements in the area drug manufacturing is critical. Here are steps and strategies than can help.
Conrad J. Heilman, Jr., PhD
Advertisement
Senior Vice President at Tunnell Consulting
Articles by Conrad J. Heilman, Jr., PhD
Advertisement
Latest Updated Articles
Manufacturing’s True North: The Quality CompassPublished: August 14th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
Direct-to-patient: pharma’s next power move
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
